Solid leukemic intracerebral deposits in patients with acute leukemia

Acute Nonlymphoblastic Leukemia: Treatment of Elderly Patients.

Leukemia & lymphoma·2016

Kinetics of Free Platelet Decrease After ADP: Effect of Fibrinogen Binding Inhibitors.

Platelets·2010

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

Genes & development·1998

Incidence of sepsis after peripheral blood progenitor cells transplantation: analysis of 86 consecutive hemato oncological patients.

Leukemia & lymphoma·1998

Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients.

Blood·1998

Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time detection of RNA.

Nucleic acids research·1998

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Haematologica·2026

Lamotrigine and other therapy-associated HLH syndromes: a review.

Expert review of clinical immunology·2026

Impact of immunoadsorption on autoantibodies and physical performance in post-COVID patients: a prospective exploratory study of 18 participants.

Infection·2026

BRAFV600E-Mutant Non-Langerhans Cell Histiocytosis Clonally Related to Remitted Acute Myeloid Leukemia.

Journal of cutaneous pathology·2026

Attenuation of Tau Hyperphosphorylation by Chronic Toxoplasma gondii Infection in a Mouse Model of Alzheimer's Disease.

Parasite immunology·2026

Single-cell Profiling of Lymphoid and Myeloid Compartments Reveals Coordinated Immune Dysregulation and Enhanced Monocyte-centric Intercellular Communication in Relapsing Polychondritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Impact of Immunosuppression Type on 30-Day Postoperative Outcomes Following Anterior Cervical Discectomy and Fusion: A Retrospective National Cohort Study of 66,162 Patients.

Global spine journal·2026

Related Experiment Videos

Solid leukemic intracerebral deposits in patients with acute leukemia

Related Concept Videos

Acute Nonlymphoblastic Leukemia: Treatment of Elderly Patients.

Kinetics of Free Platelet Decrease After ADP: Effect of Fibrinogen Binding Inhibitors.

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

Incidence of sepsis after peripheral blood progenitor cells transplantation: analysis of 86 consecutive hemato oncological patients.

Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients.

Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time detection of RNA.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Balancing remission durability and treatment burden in older acute myeloid leukemia. Comment on: "Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia".

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Defining the therapeutic window of NLRP6 modulation in graft-versus-host disease. Comment on: "NLRP6 regulates donor T cell activation and acute graft-versus-host disease via ZAP-70-Erk pathway".

Lamotrigine and other therapy-associated HLH syndromes: a review.

Impact of immunoadsorption on autoantibodies and physical performance in post-COVID patients: a prospective exploratory study of 18 participants.

BRAFV600E-Mutant Non-Langerhans Cell Histiocytosis Clonally Related to Remitted Acute Myeloid Leukemia.

Attenuation of Tau Hyperphosphorylation by Chronic Toxoplasma gondii Infection in a Mouse Model of Alzheimer's Disease.

Single-cell Profiling of Lymphoid and Myeloid Compartments Reveals Coordinated Immune Dysregulation and Enhanced Monocyte-centric Intercellular Communication in Relapsing Polychondritis.

Impact of Immunosuppression Type on 30-Day Postoperative Outcomes Following Anterior Cervical Discectomy and Fusion: A Retrospective National Cohort Study of 66,162 Patients.

Related Experiment Videos

Solid leukemic intracerebral deposits in patients with acute leukemia

Related Concept Videos

Related Articles